<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Current status of clinical trial studies on the interventions against COVID-19 across the world as of July 31, 2020 (Source: National Institute of Health, 
   <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/</ext-link>) Accessed on Aug 1, 2020
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>No.</th>
    <th>Title</th>
    <th>Status</th>
    <th>Conditions</th>
    <th>Interventions</th>
    <th>Locations</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>1</td>
    <td>Maternal-Foetal Transmission of SARS-Cov-2</td>
    <td>Recruiting</td>
    <td>
     <p>Maternal fetal infection transmission</p>
     <p>COVID-19</p>
     <p>SARS-CoV 2</p>
    </td>
    <td>Diagnostic test: diagnosis of SARS-Cov2 by RT-PCR and IgG, Ig M serologies in the amniotic fluid, the blood cord, and the placenta</td>
    <td>• CHR Orléans, Orléans, France</td>
   </tr>
   <tr>
    <td>2</td>
    <td>COVID-19 Breastfeeding Guideline for African-Americans</td>
    <td>Not yet recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>Exclusive breastfeeding</p>
    </td>
    <td>Behavioral: COVID-19 breastfeeding support</td>
    <td>• Meharry Medical College, Nashville, TN, USA</td>
   </tr>
   <tr>
    <td>3</td>
    <td>Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: diagnostic tests for COVID-19 infection</td>
    <td/>
   </tr>
   <tr>
    <td>4</td>
    <td>The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic</td>
    <td>Active, not recruiting</td>
    <td>COVID</td>
    <td>Diagnostic test: COVID 19 diagnostic test</td>
    <td>• Hong Kong Sanatorium &amp; Hospital, Hong Kong, Hong Kong</td>
   </tr>
   <tr>
    <td>5</td>
    <td>Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: lung CT scan analysis in COVID-19 patients</td>
    <td>
     <p>• Ospedale Papa Giovanni XXIII, Bergamo, Italy</p>
     <p>• Policlinico San Marco-San Donato group, Bergamo, Italy</p>
     <p>• Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy</p>
     <p>• ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy</p>
     <p>• ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy</p>
     <p>• ASST Monza, Monza, Italy</p>
     <p>• AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy</p>
     <p>• Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino, San Marino</p>
    </td>
   </tr>
   <tr>
    <td>6</td>
    <td>Study Evaluating the Safety and Efficacy of Autologous Non-hematopoietic Peripheral Blood Stem Cells in Covid-19</td>
    <td>Completed</td>
    <td>Coronavirus disease 2019 (COVID-19)</td>
    <td>
     <p>Biological: autologous non-hematopoietic peripheral blood stem cells (NHPBSC)</p>
     <p>Drug: COVID-19 standard care</p>
    </td>
    <td>• Abu Dhabi Stem Cells Center, Abu Dhabi, United Arab Emirates</td>
   </tr>
   <tr>
    <td>7</td>
    <td>Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus</td>
    <td>Recruiting</td>
    <td>High sensitivity and specificity (with 95% confidence interval) of RealDetect™ COVID-19 RT-PCR Kit</td>
    <td>Device: performance evaluation study of RealDetect RT-PCR Kit for COVID-19 detection</td>
    <td>• Institute of Epidemiology, Disease Control and Research (IEDCR), Mohakhali, Dhaka (for sample collection and sample storage), Institute for Developing Science &amp; Health Initiatives (ideSHi); Mohakhali, Dhaka (for sample analysis, data collection, data analysis), Dhaka, Bangladesh</td>
   </tr>
   <tr>
    <td>8</td>
    <td>Diagnostic Value of Patient-Reported and Clinically Verified Olfactory Disorders (COVID-19)</td>
    <td>Completed</td>
    <td>COVID-19</td>
    <td>Biological: reporting of anosmia, ageusia, and other clinical symptoms</td>
    <td>• Uhmontpellier, Montpellier, France</td>
   </tr>
   <tr>
    <td>9</td>
    <td>Smell and Taste Disorders in COVID-19 Patients</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: investigation of smell and taste disorders</td>
    <td>• ASST Monza-Ospedale San Gerardo, Monza, Italy</td>
   </tr>
   <tr>
    <td>10</td>
    <td>Neonatal Complications of Coronavirus Disease (COVID-19)</td>
    <td>Recruiting</td>
    <td>Neonatal COVID-19 disease</td>
    <td>Other: no intervention—exposure is to COVID-19</td>
    <td>• Imperial College, London, UK</td>
   </tr>
   <tr>
    <td>11</td>
    <td>COVID-19 Infection in Patients with Hepatocellular Carcinoma</td>
    <td>Recruiting</td>
    <td>
     <p>Hepatocellular carcinoma</p>
     <p>COVID-19</p>
    </td>
    <td>Diagnostic test: nasopharyngeal COVID-19 RT-PCR</td>
    <td>• CHU Amiens, Amiens, France</td>
   </tr>
   <tr>
    <td>12</td>
    <td>COVID-19 Prevalence and Cognitive Deficits in Neurological Patients</td>
    <td>Not yet recruiting</td>
    <td>
     <p>Neurological diseases or conditions</p>
     <p>Stroke, acute</p>
     <p>Seizure disorder</p>
    </td>
    <td>Diagnostic test: COVID-19 swap test PCR</td>
    <td>
     <p>• Aalborg University Hospital, Aalborg, DK, Denmark</p>
     <p>• Aarhus University Hospital, Aarhus, DK, Denmark</p>
     <p>• Regional Hospital West Jutland, Hostebro, Holstebro, DK, Denmark</p>
     <p>• Regional Hospital Central Jutland, Viborg, Viborg, DK, Denmark</p>
    </td>
   </tr>
   <tr>
    <td>13</td>
    <td>Frailty in Elderly Patients with COVID-19</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: relation between frailty and clinical outcomes in elderly patients with COVID-19</td>
    <td>• ASST Monza-Ospedale San Gerardo, Monza, Italy</td>
   </tr>
   <tr>
    <td>14</td>
    <td>COVID-19 Convalescent Plasma (CCP) Transfusion</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Biological: COVID convalescent plasma</td>
    <td>• University of Mississippi Medical Center, Jackson, MS, USA</td>
   </tr>
   <tr>
    <td>15</td>
    <td>COVID-19 in the Swedish ICU-Cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality</td>
    <td>Not yet recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>Critical illness</p>
    </td>
    <td>Other: COVID-19 and intensive care</td>
    <td/>
   </tr>
   <tr>
    <td>16</td>
    <td>MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study</td>
    <td>Enrolling by invitation</td>
    <td>COVID-19</td>
    <td>Other: COVID-19 PCR and serology testing</td>
    <td>• Duke CTSI Translational Population Health Office, Kannapolis, NC, USA</td>
   </tr>
   <tr>
    <td>17</td>
    <td>Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID)</td>
    <td>Active, not recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: ELISA and Rapid test to detect antibodies against COVID-19</td>
    <td>• Parc Tauli University Hospital, Sabadell, Barcelona, Spain</td>
   </tr>
   <tr>
    <td>18</td>
    <td>The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications</td>
    <td>Enrolling by invitation</td>
    <td>
     <p>COVID-19</p>
     <p>Coronavirus infection</p>
     <p>SARS-CoV-2</p>
     <p>Complications</p>
    </td>
    <td>Other: complex diagnostic panel</td>
    <td>• Silesian Centre for Heart Disease, Zabrze, Silesia, Poland</td>
   </tr>
   <tr>
    <td>19</td>
    <td>COVID19-Convalescent Plasma for Treating Patients with Active Symptomatic COVID 19 Infection (FALP-COVID)</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19 infection</p>
     <p>Cancer patients</p>
     <p>General population</p>
    </td>
    <td>Biological: convalescent plasma from COVID-19 donors</td>
    <td>• Fundacion Arturo Lopez Perez, Providencia, Santiago, Chile</td>
   </tr>
   <tr>
    <td>20</td>
    <td>COVID-19 Endoscopy Survey</td>
    <td>Completed</td>
    <td>COVID-19</td>
    <td>Other: practice details</td>
    <td>
     <p>• Kings County Hospital Center, Brooklyn, NY, USA; Albertson, NY, USA</p>
     <p>• Faculty of Medicine, Zagazig University, Zagazig, Sharkia, Egypt</p>
     <p>• Al-Azhar Univerisity, Cairo, Egypt</p>
     <p>• Ahvaz Imam hospital, Ahvaz, Iran, Islamic Republic of</p>
    </td>
   </tr>
   <tr>
    <td>21</td>
    <td>Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td/>
    <td>• Cliniques Universitaires Saint Luc, Brussels, Belgium</td>
   </tr>
   <tr>
    <td>22</td>
    <td>COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department</td>
    <td>Enrolling by invitation</td>
    <td>COVID-19</td>
    <td>Diagnostic test: COVID-19 test, polymerase chain reaction for SARS-CoV-2</td>
    <td>• Rigshospitalet University Hospital of Copenhagen, Copenhagen, Denmark</td>
   </tr>
   <tr>
    <td>23</td>
    <td>Viral Infection and Respiratory Illness Universal Study [VIRUS]: COVID-19 Registry</td>
    <td>Recruiting</td>
    <td>Coronavirus</td>
    <td>Other: observational</td>
    <td>
     <p>• Mayo Clinic in Arizona, Scottsdale, AZ, USA</p>
     <p>• Mayo Clinic in Florida, Jacksonville, FL, USA</p>
     <p>• Society of Critical Care Medicine (150+ sites), Chicago, IL, USA</p>
     <p>• Rahul Kashyap, Rochester, MN, USA</p>
    </td>
   </tr>
   <tr>
    <td>24</td>
    <td>Predictive Factors COVID-19 Patients</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: predictive factors for clinical response in patients with COVID-19</td>
    <td>• ASST Monza-Ospedale San Gerardo, Monza, Italy</td>
   </tr>
   <tr>
    <td>25</td>
    <td>Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt</td>
    <td>Not yet recruiting</td>
    <td>
     <p>Characteristic diseases</p>
     <p>Outcome, fatal</p>
    </td>
    <td>Other: follow-up</td>
    <td/>
   </tr>
   <tr>
    <td>26</td>
    <td>Detection of Anti-COVID-19 Antibody Levels in an Hospital Population</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: detection of anti-COVID-19 antibody level</td>
    <td>• Humanitas Rozzano/San Pio X, Rozzano, Lombardia, Italy</td>
   </tr>
   <tr>
    <td>27</td>
    <td>Isotretinoin in Treatment of COVID-19</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Drug: isotretinoin only product in oral dose form</td>
    <td/>
   </tr>
   <tr>
    <td>28</td>
    <td>Convalescent Plasma for Patients with COVID-19: a Pilot Study</td>
    <td>Not yet recruiting</td>
    <td>
     <p>Coronavirus</p>
     <p>Coronavirus infection</p>
    </td>
    <td>Drug: plasma</td>
    <td>• Universidad del Rosario, Bogota, Cundinamarca, Colombia</td>
   </tr>
   <tr>
    <td>29</td>
    <td>Slovenian National COVID-19 Prevalence Study</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>SARS-CoV-2</p>
    </td>
    <td>Diagnostic test: no intervention planned due to the observational study design—only a diagnostic testing</td>
    <td>• University of Ljubljana, Ljubljana, Slovenia</td>
   </tr>
   <tr>
    <td>30</td>
    <td>Incidence of COVID-19 Test Conversion in Post-surgical Patients</td>
    <td>Recruiting</td>
    <td>SARS-CoV-2</td>
    <td>Diagnostic test: COVID-19 PCR and serology</td>
    <td>
     <p>• North Shore University Hospital, Manhasset, NY, USA</p>
     <p>• Long Island Jewish Medical Center, New Hyde Park, NY, USA</p>
    </td>
   </tr>
   <tr>
    <td>31</td>
    <td>Novel COVID-19, a National Analysis</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: prevalence of COVID-19</td>
    <td>• Assiut University Hospitals, Assiut, Egypt</td>
   </tr>
   <tr>
    <td>32</td>
    <td>Convalescent Plasma for Patients with COVID-19: a Randomized, Open Label, Parallel, Controlled Clinical Study</td>
    <td>Not yet recruiting</td>
    <td>
     <p>Coronavirus</p>
     <p>Coronavirus infection</p>
    </td>
    <td>
     <p>Drug: plasma</p>
     <p>Drug: hydroxychloroquine</p>
    </td>
    <td>• Universidad del Rosario, Bogota, Cundinamarca, Colombia</td>
   </tr>
   <tr>
    <td>33</td>
    <td>Methodist Health System COVID-19 Patient Registry</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Other: treatment for COVID-19</td>
    <td>• Clinical Research Institute Methodist Health System, Dallas, TX, USA</td>
   </tr>
   <tr>
    <td>34</td>
    <td>Safety and Efficacy of Melatonin in Outpatients Infected with COVID-19</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Drug: melatonin</p>
     <p>Other: placebo (methylcellulose) capsule</p>
    </td>
    <td>• University at Buffalo, Buffalo, NY, USA</td>
   </tr>
   <tr>
    <td>35</td>
    <td>Discovery Stage (Proof-of-Concept) COVID-19 Antigen Presentation Therapeutic Vaccine</td>
    <td>Active, not recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Biological: COVID-19 therapeutic vaccine</p>
     <p>- Nucleocapsid-GM-CSF protein lactated Ringer’s injection</p>
    </td>
    <td>• Medicine Invention Design Incorporation (MIDI) - IORG0007849, North Bethesda, MD, USA</td>
   </tr>
   <tr>
    <td>36</td>
    <td>Dynamic Evaluation of COVID-19 Diagnostic Tests</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: COVID-19 diagnostic test</td>
    <td/>
   </tr>
   <tr>
    <td>37</td>
    <td>NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Genetic: whole genome analysis</p>
     <p>Genetic: T cell receptor (TCR) repertoire</p>
     <p>Genetic: SARS-CoV-2 viral composition</p>
    </td>
    <td/>
   </tr>
   <tr>
    <td>38</td>
    <td>Beaumont Health Large-Scale Automated Serologic Testing for COVID-19</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>Coronavirus infection</p>
     <p>Severe acute respiratory syndrome coronavirus 2</p>
    </td>
    <td>Diagnostic test: EUROIMMUN assay</td>
    <td>
     <p>• Beaumont Health System, Royal Oak, MI, USA</p>
     <p>• Beaumont Health, Royal Oak, MI, USA</p>
    </td>
   </tr>
   <tr>
    <td>39</td>
    <td>Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic</td>
    <td>Recruiting</td>
    <td>Pregnancy</td>
    <td>Diagnostic test: COVID 19 diagnostic test by PCR</td>
    <td>• University Hospital of Toulouse, Toulouse, France</td>
   </tr>
   <tr>
    <td>40</td>
    <td>Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Procedure: CT-scan with minimal invasive autopsy</td>
    <td>• Jessa Hospital, Hasselt, Belgium</td>
   </tr>
   <tr>
    <td>41</td>
    <td>Exchange Transfusion Versus Plasma from Convalescent Patients with Methylene Blue in Patients with COVID-19</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Biological: exchange blood transfusion from normal donor</p>
     <p>Biological: plasma from convalescent patients with COVID-19</p>
     <p>Drug: Methylene Blue 5 MG/ML</p>
    </td>
    <td>• Ain Shams University, Cairo, Egypt</td>
   </tr>
   <tr>
    <td>42</td>
    <td>Clinical Characteristics and Outcomes of Pediatric COVID-19</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>SARS-CoV-2 infection</p>
     <p>Pediatric ALL</p>
     <p>Pneumonia, viral</p>
     <p>Pandemic response</p>
    </td>
    <td>Other: exposure (not intervention)—SARS-CoV-2 infection</td>
    <td>• University of Calgary/Alberta Children’s Hospital, Calgary, Alberta, Canada</td>
   </tr>
   <tr>
    <td>43</td>
    <td>Relation Between Lab Finding and COVID-19 Severity</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Diagnostic test: D-dimer, CBC. ESR, CRP</p>
     <p>Diagnostic test: liver function tests, serum ferritin, and PCR for COVID-19</p>
    </td>
    <td/>
   </tr>
   <tr>
    <td>44</td>
    <td>Setting Up a COVID-19 Care Facility at a Prison in Pakistan</td>
    <td>Completed</td>
    <td>COVID-19</td>
    <td>Other: COVID-19 facility</td>
    <td>• Camp Jail/COVID-19 care facility/SIMS, Lahore, Pakistan</td>
   </tr>
   <tr>
    <td>45</td>
    <td>Impact of COVID-19 on Marshallese Communities in the U.S.</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Other: assessing impact of COVID-19</td>
    <td/>
   </tr>
   <tr>
    <td>46</td>
    <td>Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: CT scan</td>
    <td>• Tepecik Training and Research Hospital, Izmir, Izmir, Konak, Turkey</td>
   </tr>
   <tr>
    <td>47</td>
    <td>Antibody Based Tests for SARSCOV-2 COVID-19-Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test</td>
    <td>• St. David’s Medical Center, Austin, TX, USA</td>
   </tr>
   <tr>
    <td>48</td>
    <td>Spartan COVID-19 System: Evaluation of Clinical Sample Collection</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Device: Spartan COVID-19 System</td>
    <td>
     <p>• Humber River Hospital, North York, Ontario, Canada</p>
     <p>• The University of Ottawa Heart Institute, Ottawa, Ontario, Canada</p>
    </td>
   </tr>
   <tr>
    <td>49</td>
    <td>Classification of COVID-19 Infection in Posteroanterior Chest X-rays</td>
    <td>Completed</td>
    <td>COVID-19</td>
    <td>Device: CovX</td>
    <td>• Dascena, Oakland, CA, USA</td>
   </tr>
   <tr>
    <td>50</td>
    <td>Rapid, Onsite COVID-19 Detection</td>
    <td>Enrolling by invitation</td>
    <td>
     <p>COVID-19</p>
     <p>SARS-CoV-2</p>
    </td>
    <td>Device: Rapid Onsite COVID-19 detection</td>
    <td>• University of Wisconsin, Madison, WI, USA</td>
   </tr>
   <tr>
    <td>51</td>
    <td>Safety and Efficacy Of Hydroxychloroquine for At Risk Population (SHARP) Against COVID-19</td>
    <td>Not yet recruiting</td>
    <td>
     <p>Coronavirus infection</p>
     <p>Hydroxychloroquine adverse reaction</p>
    </td>
    <td>Drug: hydroxychloroquine sulfate 200 mg (mg) tab</td>
    <td/>
   </tr>
   <tr>
    <td>52</td>
    <td>Validation of COVID-19 Tests</td>
    <td>Active, not recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Diagnostic test: Covid-19 Rapid Test Kit (RAPG-COV-019)</p>
     <p>Diagnostic test: quantitative IgG test</p>
    </td>
    <td>• Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge, London, UK</td>
   </tr>
   <tr>
    <td>53</td>
    <td>Pulmonary Optical Coherence Tomography in COVID-19 Patients</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>Pulmonary embolism</p>
    </td>
    <td>Diagnostic test: optical coherence tomography (OCT)</td>
    <td>
     <p>• Incor - Heart Institute - University of Sao Paulo, São Paulo, Brazil</p>
     <p>• IRCCS San Raffaele, Milano, Italy</p>
    </td>
   </tr>
   <tr>
    <td>54</td>
    <td>COVID-19 Surveillance Based on Smart Wearable Device</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td/>
    <td>• Peking University First Hospital, Beijing, Beijing, China</td>
   </tr>
   <tr>
    <td>55</td>
    <td>Descriptive and Retrospective Analysis of Acute Myocarditis Associated with Pandemic COVID-19 in Children</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td/>
    <td>
     <p>• Hôpital Bicêtre, Le Kremlin-Bicêtre, France</p>
     <p>• Hôpital Armand Trousseau, Paris, France</p>
     <p>• Hôpital Necker-Enfants Malades, Paris, France</p>
     <p>• Hôpital Robert Debré, Paris, France</p>
    </td>
   </tr>
   <tr>
    <td>56</td>
    <td>Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: COVID-19 antibodies testing</td>
    <td/>
   </tr>
   <tr>
    <td>57</td>
    <td>A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Drug: suspension of heat killed (autoclaved) Mycobacterium w</p>
     <p>Drug: standard therapy of COVID-19</p>
    </td>
    <td>
     <p>• All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India</p>
     <p>• All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India</p>
     <p>• Postgraduate Institute of Medical Education and Research, Chandigarh, India</p>
     <p>• All lndia Institute of Medical Science, Delhi, Delhi, India</p>
    </td>
   </tr>
   <tr>
    <td>58</td>
    <td>Convalescent Plasma In ICU Patients With COVID-19-Induced Respiratory Failure</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>SARS-CoV-2</p>
    </td>
    <td>Biological: multiple doses of anti-SARS-CoV-2 convalescent plasma</td>
    <td>
     <p>• 8700 Beverly Blvd., Los Angeles, CA, USA</p>
     <p>• Johns Hopkins University, Baltimore, MD, USA</p>
    </td>
   </tr>
   <tr>
    <td>59</td>
    <td>Immunoglobulin G Antibody Immune Response Profile Following Infection with SARS-CoV-2 in COVID-19 Egyptian Patients</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td/>
    <td>• Sohag University Hospital, Sohag, Egypt</td>
   </tr>
   <tr>
    <td>60</td>
    <td>Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection</td>
    <td>Recruiting</td>
    <td>Severe acute respiratory syndrome coronavirus 2</td>
    <td>Biological: COVID-19 convalescent plasma</td>
    <td>• Hospital Clínico Universidad Católica, Santiago, Chile</td>
   </tr>
   <tr>
    <td>61</td>
    <td>Will Hydroxychloroquine Impede or Prevent COVID-19</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>Coronavirus</p>
     <p>Coronavirus infections</p>
     <p>SARS-CoV-2</p>
    </td>
    <td>
     <p>Drug: Hydroxychloroquine—daily dosing</p>
     <p>Drug: hydroxychloroquine—weekly dosing</p>
     <p>Other: placebo oral tablet</p>
     <p>Diagnostic test: monitoring visit—baseline</p>
     <p>Diagnostic test: monitoring visit—week 4</p>
     <p>Diagnostic test: monitoring visit—week 8</p>
     <p>Other: weekly assessment</p>
    </td>
    <td>
     <p>• Henry Ford Hospital, Detroit, MI, USA</p>
     <p>• Detroit Department of Transportation (DDOT), Detroit, MI, USA</p>
     <p>• Detroit Fire Department &amp; Detroit EMS, Detroit, MI, USA</p>
     <p>• Detroit Police Department, Detroit, MI, USA</p>
    </td>
   </tr>
   <tr>
    <td>62</td>
    <td>Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19: a Randomized Control Trial</td>
    <td>Not yet recruiting</td>
    <td>
     <p>SARS-CoV-2 infections</p>
     <p>COVID-19</p>
    </td>
    <td>Drug: oral</td>
    <td>• Assistant Professor Subsai Kongsaengdao, Bangkok, Thailand</td>
   </tr>
   <tr>
    <td>63</td>
    <td>Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: data monitoring for 48 h within the first 12 h of admission for COVID-19</td>
    <td>
     <p>• Louis Mourier hospital (AP-HP), Colombes, France</p>
     <p>• Brabois Hospital (CHRU de Nancy), Vandœuvre-lès-Nancy, France</p>
    </td>
   </tr>
   <tr>
    <td>64</td>
    <td>Effects on the Qt Interval of COVID-19 Coronavirus Infection</td>
    <td>Recruiting</td>
    <td>
     <p>Coronavirus infection</p>
     <p>Intensive care patients</p>
    </td>
    <td/>
    <td>• Servicio de Anestesia, Hospital General Universitario Gregorio Marañon, Madrid, Spain</td>
   </tr>
   <tr>
    <td>65</td>
    <td>COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients with Pneumonia Caused by SARS- CoV-2</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Biological: COVID-19 convalescent plasma</td>
    <td>• Hospital of the University of Pennsylvania, Philadelphia, PA, USA</td>
   </tr>
   <tr>
    <td>66</td>
    <td>COVID-19 Pandemic and Worldwide Organ Procurement</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td/>
    <td>• Paris Transplant Group, Paris, France</td>
   </tr>
   <tr>
    <td>67</td>
    <td>Testing the Accuracy of a Digital Test to Diagnose Covid-19</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: COVID-19 swab PCR test</td>
    <td>• King’s College London, London, United Kingdom</td>
   </tr>
   <tr>
    <td>68</td>
    <td>Clinical Trial of Allogeneic Mesenchymal Cells from Umbilical Cord Tissue in Patients with COVID-19</td>
    <td>Recruiting</td>
    <td>COVID</td>
    <td>
     <p>Biological: mesenchymal cells</p>
     <p>Drug: standard of care</p>
    </td>
    <td>
     <p>• Hospital Universitario de Getafe, Getafe, Madrid, Spain</p>
     <p>• Hospital Universitario de Cruces, Barakaldo, Spain</p>
     <p>• Hospital Universitario de La Princesa, Madrid, Spain</p>
     <p>• Hospital Infantil Universitario Niño Jesus, Madrid, Spain</p>
     <p>• Hospital Ramón Y Cajal, Madrid, Spain</p>
     <p>• Complejo Universitario La Paz, Madrid, Spain</p>
    </td>
   </tr>
   <tr>
    <td>69</td>
    <td>The Heart Hive COVID-19 Study</td>
    <td>Not yet recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>Cardiomyopathies</p>
    </td>
    <td>Other: COVID-19 experience surveys</td>
    <td>• Imperial College London, London, UK</td>
   </tr>
   <tr>
    <td>70</td>
    <td>National Survey of Symptoms of People Aged 70 and Overs Diagnosed with COVID-19</td>
    <td>Completed</td>
    <td>
     <p>SARS-CoV-2</p>
     <p>COVID-19</p>
    </td>
    <td>Other: observation</td>
    <td>• Angers University Hospital, Angers, France</td>
   </tr>
   <tr>
    <td>71</td>
    <td>Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>Health personnel</p>
     <p>Personnel, hospital</p>
    </td>
    <td>Other: serial seroconversion measurements in hospital employees during the COVID-19 pandemic</td>
    <td>
     <p>• Nordsjællands Hospital, Hillerød, Capital Region, Denmark</p>
     <p>• Nykøbing Falster County Hospital, Nykøbing Falster, Southern Region, Denmark</p>
    </td>
   </tr>
   <tr>
    <td>72</td>
    <td>Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Biological: adsorbed COVID-19 (inactivated) vaccine</p>
     <p>Biological: placebo</p>
    </td>
    <td>
     <p>• Universidade de Brasília, Brasilia, DF, Brazil</p>
     <p>• Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil</p>
     <p>• Hospital das Clínicas da Universidade Federal do Paraná, Curitiba, PR, Brazil</p>
     <p>• Hospital São Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS, Brazil</p>
     <p>• Hospital das Clínicas da UNICAMP, Campinas, SP, Brazil</p>
     <p>• Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirao Preto, SP, Brazil</p>
     <p>• Instituto de Infectologia Emílio Ribas, Sao Paulo, SP, Brazil</p>
     <p>• Centro de Pesquisas Clínicas do Instituto Central do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil</p>
     <p>• Instituto Israelita de Ensino e Pesquisa Albert Einstein, Sao Paulo, SP, Brazil</p>
     <p>• Universidade Municipal de São Caetano do Sul, São Caetano do Sul, SP, Brazil</p>
     <p>• Faculdade de Medicina de São José do Rio Preto - FAMERP, São José Do Rio Preto, São Paulo, Brazil</p>
     <p>• Instituto de Infectologia Evandro Chagas - Fiocruz, Rio De Janeiro, Brazil</p>
    </td>
   </tr>
   <tr>
    <td>73</td>
    <td>Gut Microbiota, “Spark and Flame” of COVID-19 Disease</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: exposure</td>
    <td>
     <p>• Hospital CUF Infante Santo, S.A., Lisbon, Portugal</p>
     <p>• Hospital de São Francisco Xavier, Lisbon, Portugal</p>
     <p>• Centro Hospitalar Universitário São João, Oporto, Portugal</p>
    </td>
   </tr>
   <tr>
    <td>74</td>
    <td>Antioxidant Therapy for COVID-19 Study</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Dietary supplement: antioxidation therapy</p>
     <p>Other: standard of care</p>
    </td>
    <td>
     <p>• Abia State Isolation Centre, Amachara, Umuahia, Abia State, Nigeria</p>
     <p>• Benue State University Teaching Hospital, Makurdi, Benue State, Nigeria</p>
     <p>• Brigadier Abba Kyari Memorial Hospital, Borno, Borno State, Nigeria</p>
     <p>• University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria</p>
     <p>• University of Calabar Teaching Hospital, Calabar, Cross River, Nigeria</p>
     <p>• Federal Medical Centre Idi-Aba, Abeokuta, Ogun State, Nigeria</p>
     <p>• Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria</p>
     <p>• Infectious Disease Hospital, Amanawa, Sokoto State, Nigeria</p>
     <p>• Murtala Muhammad Speciaist Hospital, Sokoto, Sokoto State, Nigeria</p>
     <p>• Occupational Therapy Center, Sokoto, Sokoto State, Nigeria</p>
     <p>• Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State, Nigeria</p>
    </td>
   </tr>
   <tr>
    <td>75</td>
    <td>COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: BioMedomics COVID-19 IgM-IgG Rapid Test</td>
    <td>• AO San Paolo, Milan, IT, Italy</td>
   </tr>
   <tr>
    <td>76</td>
    <td>Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic</td>
    <td>Completed</td>
    <td>COVID-19</td>
    <td>Diagnostic test: COVID-19 diagnostic PCR</td>
    <td>• Seda Yilmaz Semerci, Istanbul, Turkey</td>
   </tr>
   <tr>
    <td>77</td>
    <td>Inhaled Nitric Oxide for Preventing Progression in COVID-19</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Drug: nitric oxide</td>
    <td>• Tufts Medical Center, Boston, MA, USA</td>
   </tr>
   <tr>
    <td>78</td>
    <td>Cohort of Patients Infected with SARS-CoV2 (COVID-19) or Suspected of Being</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Other: blood samples</td>
    <td>• GH Pitié-Salpêtrière / Service d’Accueil des Urgences, Paris, Ile- de-France, France</td>
   </tr>
   <tr>
    <td>79</td>
    <td>Hydrogen-Oxygen Generator with Nebulizer in the Improvement of Symptoms in Patients Infected with COVID-19</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Device: oxyhydrogen</p>
     <p>Device: oxygen</p>
    </td>
    <td>• First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China</td>
   </tr>
   <tr>
    <td>80</td>
    <td>Endovascular Thrombectomy in COVID-19 Infected Patients</td>
    <td>Completed</td>
    <td>
     <p>Ischemic stroke</p>
     <p>COVID-19</p>
    </td>
    <td>Other: mechanical trombectomy</td>
    <td>• Uhmontpellier, Montpellier, France</td>
   </tr>
   <tr>
    <td>81</td>
    <td>Pre-exposure Prophylaxis with Hydroxychloroquine for High- Risk Healthcare Workers During the COVID-19 Pandemic</td>
    <td>Suspended</td>
    <td>COVID-19</td>
    <td>
     <p>Drug: hydroxychloroquine</p>
     <p>Drug: placebos</p>
    </td>
    <td>• ISGlobal, Barcelona, Spain</td>
   </tr>
   <tr>
    <td>82</td>
    <td>Evaluating Clinical Parameters of COVID-19 in Pregnancy</td>
    <td>Not yet recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>2019 novel coronavirus infection</p>
     <p>COVID-19 infection</p>
    </td>
    <td/>
    <td>• Chelsea and Westminster Hospital NHS Foundation Trust, London, UK</td>
   </tr>
   <tr>
    <td>83</td>
    <td>Characteristics of COVID-19 Infection Among PREGnant Women</td>
    <td>Recruiting</td>
    <td>
     <p>Coronavirus infection</p>
     <p>Pregnancy related</p>
    </td>
    <td>Other: COVID-19 positive via testing</td>
    <td>• INOVA Health System, Falls Church, VA, USA</td>
   </tr>
   <tr>
    <td>84</td>
    <td>Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia</td>
    <td>Active, not recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>SARS-CoV-2</p>
    </td>
    <td/>
    <td>• Uh Montpellier, Montpellier, France</td>
   </tr>
   <tr>
    <td>85</td>
    <td>Implementation of Physiotherapy on COVID-19 Patients in ICU</td>
    <td>Recruiting</td>
    <td>
     <p>SARS-CoV-2</p>
     <p>COVID-19</p>
    </td>
    <td>Other: physiotherapy</td>
    <td>• Uhmontpellier, Montpellier, France</td>
   </tr>
   <tr>
    <td>86</td>
    <td>Tableted COVID-19 Therapeutic Vaccine</td>
    <td>Active, not recruiting</td>
    <td>COVID-19</td>
    <td>Biological: V-SARS</td>
    <td>
     <p>• Immunitor Inc., Vancouver, BC - British Columbia, Canada</p>
     <p>• Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo, Mongolia</p>
    </td>
   </tr>
   <tr>
    <td>87</td>
    <td>Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-Associated Complications in Hospitalized Patients</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>SARS-CoV-2</p>
    </td>
    <td>
     <p>Biological: COVID-19 convalescent plasma (CCP)</p>
     <p>Biological: placebo</p>
    </td>
    <td>
     <p>• San Francisco General Hospital, San Francisco, CA, USA</p>
     <p>• UCSF Medical Center at Mount Zion, San Francisco, CA, USA</p>
     <p>• University of California, San Francisco Medical Center (Parnassus Campus), San Francisco, CA, USA</p>
    </td>
   </tr>
   <tr>
    <td>88</td>
    <td>Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Device: Kerecis oral and nasal spray</p>
     <p>Other: placebo</p>
    </td>
    <td>• National Hospital of Iceland (Landspítali), Reykjavík, Iceland</td>
   </tr>
   <tr>
    <td>89</td>
    <td>Anti COVID-19 Convalescent Plasma Therapy</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Biological: anti-SARS-CoV-2 convalescent plasma</td>
    <td/>
   </tr>
   <tr>
    <td>90</td>
    <td>Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Other: deep venous disease diagnostic</td>
    <td>• Red de Investigacion Vascular (SEACV), Madrid, Spain</td>
   </tr>
   <tr>
    <td>91</td>
    <td>Elmo Respiratory Support Project - COVID-19</td>
    <td>Not yet recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>Respiratory failure with hypoxia</p>
    </td>
    <td>
     <p>Other: Elmo Project at COVID-19: study in humans</p>
     <p>Device: Elmo Project at COVID-19: proof of concept and usability</p>
    </td>
    <td/>
   </tr>
   <tr>
    <td>92</td>
    <td>Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia</td>
    <td>Recruiting</td>
    <td>COVID-19 pneumonia</td>
    <td>
     <p>Drug: plasma from COVID-19 convalescent patient</p>
     <p>Drug: human immunoglobulin</p>
    </td>
    <td>• Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico</td>
   </tr>
   <tr>
    <td>93</td>
    <td>Observational Cohort of COVID-19 Patients at Raymond- Poincare</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td/>
    <td>• Department of Infectiology, Raymond Poincaré Hospital, APHP, Garches, France</td>
   </tr>
   <tr>
    <td>94</td>
    <td>Longitudinal Energy Expenditure and Metabolic Effects in Patients with COVID-19 (LEEP-COVID)</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Device: Q-NRG Metobolic Cart Device</p>
     <p>Device: MuscleSound Ultrasound</p>
     <p>Device: multifrequency bioimpedance spectroscopy</p>
    </td>
    <td>• Duke University Medial Center, Durham, NC, USA</td>
   </tr>
   <tr>
    <td>95</td>
    <td>Part Two of Novel Adoptive Cellular Therapy with SARS- CoV-2 Specific T Cells in Patients with Severe COVID-19</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Biological: SARS-CoV-2 specific T cells</td>
    <td>
     <p>• Changi General Hospital, Singapore, Singapore</p>
     <p>• KK Women’s and Children’s Hospital, Singapore, Singapore</p>
     <p>• National University Hospital, Singapore, Singapore</p>
     <p>• Sengkang General Hospital, Singapore, Singapore</p>
     <p>• Singapore General Hospital, Singapore, Singapore</p>
    </td>
   </tr>
   <tr>
    <td>96</td>
    <td>A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients with COVID-19 Infection</td>
    <td>Recruiting</td>
    <td>COVID-19</td>
    <td>Biological: anti-SARS-CoV-2 convalescent plasma</td>
    <td>• Froedtert Hospital, Milwaukee, WI, USA</td>
   </tr>
   <tr>
    <td>97</td>
    <td>Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic</td>
    <td>Recruiting</td>
    <td>
     <p>COVID-19</p>
     <p>interstitial pneumonia</p>
    </td>
    <td/>
    <td>• IRCCS Policlinico San Donato, San Donato Milanese, MI, Italy</td>
   </tr>
   <tr>
    <td>98</td>
    <td>CORonavirus (COVID-19) Diagnostic Lung UltraSound Study</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>Diagnostic test: lung ultrasound</td>
    <td/>
   </tr>
   <tr>
    <td>99</td>
    <td>Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19</td>
    <td>Not yet recruiting</td>
    <td>Coronavirus disease 2019 (COVID-19)</td>
    <td>
     <p>Biological: COVID-19 convalescent plasma</p>
     <p>Biological: anti-COVID-19 human immunoglobulin</p>
     <p>Drug: standard (specific) therapy for COVID-19</p>
    </td>
    <td>• LifeFactors Zona Franca SAS, Medellín, Antioquia, Colombia</td>
   </tr>
   <tr>
    <td>100</td>
    <td>Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients</td>
    <td>Not yet recruiting</td>
    <td>COVID-19</td>
    <td>
     <p>Drug: tramadol</p>
     <p>Other: standard care delivered in the isolation hospitals</p>
    </td>
    <td/>
   </tr>
  </tbody>
 </table>
</table-wrap>
